Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.7157 | 62 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.3944 | 70 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.53456 | 72 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 4.12526 | 67 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.81003 | 74 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.48353 | 72 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.47844 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.51662 | 72 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.39028 | 70 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.34007 | 70 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.26231 | 69 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.39266 | 70 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.50392 | 71 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.41808 | 71 |